Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 5/24/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.84 | 0.69 | 21.99 |
| EPS, GAAP | 0.78 | 0.55 | 0.55 |
| Consensus Estimate | 1.00 | 0.90 | 10.70 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.23 | 3.16 | 1.98 |
| EPS, GAAP | 3.02 | 2.97 | 1.47 |
| Consensus Estimate | 4.65 | 4.17 | 11.56 |
| ABT | Industry Average | |
| P/E (TTM) | 19.43 | NA |
| P/E (Forward) | 12.30 | NA |
| PEG Ratio | 1.40 | 2.17 |
| Price/Sales | 2.48 | 4.18 |
| Beta | 0.48 | 0.62 |
| 9:20 AM | 5/22/2012 | Abbott Bid For US Approval Of New Use For Humira Is Delayed |
| 2:43 PM | 5/21/2012 | J&J's Simponi Helps Colitis Patients In Clinical Trial |
| 5/23/2012 | Can US Biotechs Inject Life To Australia's IPO Market? (WSJ.com) |
| 5/16/2012 | Piramal Sees More Opportunities in U.S. Than India (WSJ.com) |
| 5/10/2012 | India's Antitrust Regulator Turns Up the Heat (WSJ.com) |
| 5/9/2012 | Deals of the Day: Glaxo Goes Hostile for Human Genome (WSJ.com) |
| 5/7/2012 | Abbott to Pay $1.6 Billion in Settlement (WSJ.com) |
| 5/7/2012 | Barron's 500 (Barrons.com) |
| 5/7/2012 | Bravo to the Best! (Barrons.com) |
| 5/4/2012 | Cipla Cuts Prices of Cancer Drugs in India (WSJ.com) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)
